Name | Type | Posted | Actions |
|---|---|---|---|
Exhibit D 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit C 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit B 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit A 6Mar25.docx | DOCX | Mar 6, 2025 | |
Exhibit E 6Mar25.docx | DOCX | Mar 6, 2025 | |
HT940625R0004 Conformed P00003.pdf | Mar 6, 2025 | ||
Exhibit E 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit D 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit C 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit B 25Feb25.docx | DOCX | Feb 25, 2025 | |
Exhibit A 25Feb25.docx | DOCX | Feb 25, 2025 | |
HT940625R0004 Conformed P00002.pdf | Feb 25, 2025 | ||
HT940625R0004 Conformed.pdf | Feb 13, 2025 | ||
Exhibit E.docx | DOCX | Feb 13, 2025 | |
Exhibit D.docx | DOCX | Feb 13, 2025 | |
Exhibit C.docx | DOCX | Feb 13, 2025 | |
Exhibit B.docx | DOCX | Feb 13, 2025 | |
Exhibit A.docx | DOCX | Feb 13, 2025 | |
Exhibit B.docx | DOCX | Feb 10, 2025 | |
Exhibit C.docx | DOCX | Feb 10, 2025 | |
Exhibit D.docx | DOCX | Feb 10, 2025 | |
Exhibit E.docx | DOCX | Feb 10, 2025 | |
HT940625R0004.pdf | Feb 10, 2025 | ||
Exhibit A.docx | DOCX | Feb 10, 2025 |
Radiopharmaceuticals - Naval Medical Center Portsmouth
Contact and place of performance
Carol Uebelacker
Portsmouth, VA 23708
USA
Defense Health Agency (DHA) has a requirement for a Firm Fixed Price (FFP) IDIQ supply contract in accordance with FAR Part 12, Commercial Items and FAR Part 13, Simplified Acquisition Procedures for General Nuclear Medicine Radiopharmaceuticals (GNMR) at Naval Medical Center Portsmouth (NMCP) VA. In order to be considered for this requirement, please respond with a completed proposal following the guidelines starting on page 3 of the SF1449.
The Defense Health Agency (DHA) has issued solicitation HT940625R0004 for a firm-fixed-price, indefinite-delivery/indefinite-quantity (IDIQ) supply contract. This requirement provides general nuclear medicine radiopharmaceuticals (GNMR) to the Naval Medical Center Portsmouth (NMCP) in Portsmouth, Virginia. The acquisition is conducted in accordance with procedures for commercial items and simplified acquisition procedures, with 24 total attachments available including conformed solicitation documents and various exhibits.
The procurement is classified under NAICS code 325412, Pharmaceutical Preparation Manufacturing, and PSC 6505, Drugs and Biologicals. Proposals must be submitted following the specific guidelines provided in the solicitation document. The response deadline for this opportunity is March 11, 2025, and Carol Uebelacker is the designated point of contact for the effort.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.